Ustekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis

Background Perianal Crohn’s disease (pCD) is a debilitating complication affecting up to 30% of Crohn’s disease (CD) population, leading to increased morbidity, mortality and decreased quality of life. Despite the growing armamentarium of medications for luminal CD, their efficacy in pCD remains poo...

詳細記述

書誌詳細

主要な著者:	Berkeley N Limketkai, Mark Lazarev, George Salem, Gala M Godoy Brewer, Muhammad A Afzal, Zadid Haq, Maryam Tajamal, Joanna Melia, Florin M Selaru, Alyssa M. Parian
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMJ Publishing Group 2021-10-01
シリーズ:	BMJ Open Gastroenterology
オンライン･アクセス:	https://bmjopengastro.bmj.com/content/8/1/e000702.full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!